Compare RYTM & HR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYTM | HR |
|---|---|---|
| Founded | 2008 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.9B |
| IPO Year | 2017 | 1993 |
| Metric | RYTM | HR |
|---|---|---|
| Price | $98.07 | $17.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 8 |
| Target Price | ★ $128.31 | $19.57 |
| AVG Volume (30 Days) | 967.0K | ★ 2.9M |
| Earning Date | 02-25-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 5.63% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $174,334,000.00 | ★ $1,204,680,000.00 |
| Revenue This Year | $47.34 | N/A |
| Revenue Next Year | $55.95 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 54.92 | N/A |
| 52 Week Low | $45.91 | $14.09 |
| 52 Week High | $122.20 | $18.97 |
| Indicator | RYTM | HR |
|---|---|---|
| Relative Strength Index (RSI) | 36.87 | 46.45 |
| Support Level | $97.38 | $16.72 |
| Resistance Level | $103.20 | $17.49 |
| Average True Range (ATR) | 4.20 | 0.27 |
| MACD | -1.61 | 0.05 |
| Stochastic Oscillator | 12.15 | 53.74 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.